ArticleOncotarget2023

Correction: HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide.

Alessandro Canella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.